HDL in innate and adaptive immunity.

Area of Science:

• Immunology
• Cardiovascular Research
• Metabolic Disorders

Background:

• High-density lipoproteins cholesterol (HDL-C) levels decrease rapidly during infections and acute conditions.
• HDL particles undergo significant compositional and functional changes, correlating with poor prognosis in sepsis and endotoxemia.
• Genetic animal models and parasitic infection studies highlight a protective role for HDL, particularly its component apoL-1.

Purpose of the Study:

• To review the intricate relationship between HDL and the immune system.
• To explore HDL's role in both innate and adaptive immunity.
• To discuss HDL's involvement in atherosclerosis and other conditions.

Main Methods:

• Literature review synthesizing data from clinical observations, genetic animal models, and infection studies.
• Analysis of HDL's influence on immune cell lipid rafts and receptor modulation.
• Examination of HDL-mediated transport of immune-modulating molecules like sphingosine-1-phosphate (S1P).

Main Results:

• HDL influences immune cell cholesterol availability, modulating Toll-like receptors, MHC-II, and B/T-cell receptors.
• HDL-associated molecules like S1P are critical for immune cell trafficking.
• Defects in HDL metabolism or cholesterol efflux are linked to immune disorders.

Conclusions:

• HDL functions as a critical platform integrating innate and adaptive immunity.
• HDL's dynamic changes during infection impact disease outcomes.
• Understanding HDL-immunity interactions is vital for atherosclerosis and beyond.